**Albemarle Corporation (ALB), American Airlines Group Inc. (AAL), and Aquestive Therapeutics, Inc. (AQST) have been added to the Zacks Rank #5 (Strong Sell) List.** As of now, Albemarle’s earnings estimate for the current year has been revised downward by 29.1%, while American Airlines’ has decreased by 22.1%. Aquestive Therapeutics has also seen a downward revision of nearly 16.7% in its earnings estimates over the past 60 days.
These significant changes highlight a challenging outlook for these companies, impacting investor sentiment and stock performance.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
